To determine whether VB1 regulation of the NF-κB signal depends on PPAR-γ, we used rosiglitazone, an agonist of PPAR-γ, to activate PPAR-γ after VB1 treatment in macrophages with H37Rv infection. This evidence concerns the gene PPARG and infection.